Hypoglycemia in Diabetes: Evidence-Based Treatments and Risk Reduction

Evidence related to hypoglycemia

Evidence related to hypoglycemia events, severe hypoglycemia, time below range, postprandial hypoglycemia, symptom recognition, and diabetes interventions that affect low blood sugar risk.

Build your Evidence Workspace

Save evidence about the topics you care about.

Studies

Evidence Pairs

Strong Research Support

Relationship Confidence: 78/100

Evidence guide

What does the evidence say?

Does Hybrid closed-loop system affect Hypoglycemia events?

Current evidence does not establish a clear direction of effect for Hypoglycemia events with Hybrid closed-loop system.

View answer

Does Insulin therapy reduce Hypoglycemia events?

Insulin therapy may reduce Hypoglycemia events.

View answer

Does Hybrid closed-loop system lower Time below range?

Hybrid closed-loop system may lower Time below range.

View answer

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Hypoglycemia evidence appears to center on Continuous glucose monitoring.

Among 20 indexed studies and 7 interventions, the strongest signals are summarized from the available evidence. Hybrid closed-loop system has been studied often, while Continuous glucose monitoring appears to have stronger current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Continuous glucose monitoring appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 3 evidence pairs - 6 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTs

Continuous glucose monitoring

6 studies

EvidenceScore™

79/100

ConsistencyScore™

67/100

Evidence Snapshot

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Neutral signal

Hybrid closed-loop system shows limited or neutral effect on Hypoglycemia events

Hybrid closed-loop system → Hypoglycemia events

Across 5 studies, Hybrid closed-loop system shows a neutral signal for Hypoglycemia events.

5 studies

EvidenceScore™: 84.6923076923077/100

View supporting studies

Evidence signal

Continuous glucose monitoring shows evidence for Time below range

Continuous glucose monitoring → Time below range

Across 4 studies, Continuous glucose monitoring shows a consistent evidence signal for Time below range.

4 studies

EvidenceScore™: 79/100

View supporting studies

Evidence signal

Insulin therapy shows evidence for Hypoglycemia events

Insulin therapy → Hypoglycemia events

Across 3 studies, Insulin therapy shows a evidence signal for Hypoglycemia events.

3 studies

EvidenceScore™: 79/100

View supporting studies

Moderate positive signal

Hybrid closed-loop system may improve Time below range

Hybrid closed-loop system → Time below range

Across 3 studies, Hybrid closed-loop system shows a moderate positive signal for Time below range.

3 studies

EvidenceScore™: 78.3076923076923/100

View supporting studies

Neutral signal

Insulin pump shows limited or neutral effect on Time below range

Insulin pump → Time below range

Across 2 studies, Insulin pump shows a neutral signal for Time below range.

2 studies

EvidenceScore™: 69/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Hybrid closed-loop system is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Hybrid closed-loop system

Continuous glucose monitoring

Hybrid closed-loop system

9 studies

EvidenceScore™

85/100

ConsistencyScore™

60/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 11 evidence pairs - 16 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Insulin therapy may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Insulin therapy

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)

Insulin therapy

3 studies

EvidenceScore™

79/100

ConsistencyScore™

36/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength

Evidence basis: 3 evidence pairs - 4 studies

View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Questions Answered by the Evidence

Does Hybrid closed-loop system affect Hypoglycemia events?

Current evidence does not establish a clear direction of effect for Hypoglycemia events with Hybrid closed-loop system.

Strong Evidence · Results are generally consistent across studies. · 5 studies · 5 RCTs

View answer

Does Insulin therapy reduce Hypoglycemia events?

Insulin therapy may reduce Hypoglycemia events.

Strong Evidence · Results are mixed and should be interpreted cautiously. · 3 studies · 3 RCTs

The evidence includes both beneficial and harmful or worsening results.

View answer

Does Continuous glucose monitoring improve time below range?

Continuous glucose monitoring may improve time below range.

Strong Evidence · Results are consistent across studies. · 4 studies · 4 RCTs

View top evidence signals ↓

Continuous glucose monitoring · Strong · 4 studies

Does Hybrid closed-loop system lower Time below range?

Hybrid closed-loop system may lower Time below range.

Strong Evidence · Results are generally consistent across studies. · 3 studies · 3 RCTs

View answer

Does Insulin pump affect Time below range?

Current evidence does not establish a clear direction of effect for Time below range with Insulin pump.

Moderate Evidence · Results are mixed and should be interpreted cautiously. · 2 studies · 2 RCTs

Some evidence reported benefits while other evidence found little or no effect.

View answer

Browse all questions about Hypoglycemia

Overall Evidence Signals

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Evidence Relationships

Explore the intervention-outcome relationships with the strongest supporting evidence for Hypoglycemia.

4 strong relationships, ranked by available evidence

Hybrid closed-loop system → Hypoglycemia events

EvidenceScore™: 85; Strong

Based on 5 studies

View supporting studies

Insulin therapy → Hypoglycemia events

EvidenceScore™: 79; Strong

Based on 3 studies

View supporting studies

Continuous glucose monitoring → Time below range

EvidenceScore™: 79; Strong

Based on 4 studies

View supporting studies

Hybrid closed-loop system → Time below range

EvidenceScore™: 78; Strong

Based on 3 studies

View supporting studies

Select any relationship to review its supporting studies.

Supporting Research

Selected studies that best represent the evidence behind this topic.

Artificial pancreas may improve glucose control in type 1 diabetes

Highly relevant

Interventions:

Hybrid closed-loop system Insulin therapy

Outcomes:

Hypoglycemia events Time below range

View research summary→

Equil patch insulin pump shows similar efficacy to Medtronic pump in T2DM management

Representative

Interventions:

Insulin pump

Outcomes:

Hypoglycemia events Time below range

View research summary→

Cloud platform improves algorithm testing for type 1 diabetes

Representative

Interventions:

Hybrid closed-loop system Insulin therapy

Outcomes:

Hypoglycemia events

View research summary→

Efsitora improves HbA1c control compared to degludec in Japanese adults.

Representative

Interventions:

Insulin degludec

Outcomes:

Severe hypoglycemia

View research summary→

Automated insulin delivery improves glucose management in diabetes with CKD

Representative

Interventions:

Continuous glucose monitoring Hybrid closed-loop system

Outcomes:

Hypoglycemia symptom score

View research summary→

Automated insulin delivery reduces hypoglycemia risk

Representative

Interventions:

Hybrid closed-loop system Insulin pump

Outcomes:

Time below range

View research summary→

Click any study to view the full research summary, or click interventions and outcomes to filter Evidence Explorer.

Continue exploring

Related evidence briefs

Insulin Therapies Diabetes Technology

Evidence Tracker

Track Hypoglycemia in Diabetes: Evidence-Based Treatments and Risk Reduction evidence

Save this evidence topic and revisit it as new studies are added.